RUA Life Sciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 17, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	16	7	7	6	11	11
Market Cap Growth	118.56%	-6.25%	33.33%	-51.11%	5.10%	-65.37%
Enterprise Value	15	5	5	6	9	6
Last Close Price	0.27	0.11	0.12	0.09	0.52	0.49
PE Ratio	58.40	-	7447.23	-	-	-
PS Ratio	3.56	1.57	1.81	2.55	5.24	6.69
PB Ratio	2.34	0.97	1.01	0.78	2.44	1.65
P/TBV Ratio	2.57	1.08	1.13	0.86	2.92	1.89
EV/Sales Ratio	3.20	1.02	1.21	2.53	4.30	3.99
EV/EBITDA Ratio	25.69	16.68	12.39	-	-	-
Debt / Equity Ratio	0.09	0.11	0.14	0.05	0.10	0.05
Debt / EBITDA Ratio	1.13	2.92	2.57	-	-	-
Net Debt / Equity Ratio	-0.24	-0.34	-0.34	-0.49	-0.21	-0.40
Net Debt / EBITDA Ratio	-2.98	-9.03	-6.33	2.25	0.52	1.28
Net Debt / FCF Ratio	1.68	10.41	9.03	2.56	0.63	0.80
Asset Turnover	-	-	0.47	0.32	0.33	0.18
Inventory Turnover	-	-	2.17	4.92	4.40	3.39
Quick Ratio	4.44	3.62	4.23	8.40	4.60	7.32
Current Ratio	5.92	4.64	4.91	9.01	5.20	8.23
Return on Equity (ROE)	-	-	0.01%	-24.27%	-35.55%	-27.40%
Return on Assets (ROA)	-	-	-0.14%	-17.51%	-21.69%	-16.54%
Return on Capital Employed (ROCE)	1.80%	-2.20%	-0.20%	-25.40%	-43.90%	-33.10%
Earnings Yield	1.71%	-2.08%	0.01%	-25.78%	-17.53%	-19.02%
FCF Yield	-6.21%	-3.38%	-3.77%	-24.76%	-13.96%	-29.96%
Buyback Yield / Dilution	-	-	-85.00%	-51.21%	-	-25.36%